Equillium Inc (EQ)
1.45
+0.05
(+3.57%)
USD |
NASDAQ |
May 28, 16:00
1.45
0.00 (0.00%)
After-Hours: 16:17
Equillium Cash from Operations (TTM): -22.59M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -22.59M |
December 31, 2023 | -21.78M |
September 30, 2023 | 11.61M |
June 30, 2023 | 0.45M |
March 31, 2023 | -4.594M |
December 31, 2022 | -8.733M |
September 30, 2022 | -46.59M |
June 30, 2022 | -40.54M |
March 31, 2022 | -36.27M |
December 31, 2021 | -32.08M |
September 30, 2021 | -30.20M |
Date | Value |
---|---|
June 30, 2021 | -28.11M |
March 31, 2021 | -26.20M |
December 31, 2020 | -24.62M |
September 30, 2020 | -25.40M |
June 30, 2020 | -25.18M |
March 31, 2020 | -24.86M |
December 31, 2019 | -22.95M |
September 30, 2019 | -17.74M |
June 30, 2019 | -14.69M |
March 31, 2019 | -11.10M |
December 31, 2018 | -7.526M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-46.59M
Minimum
Sep 2022
11.61M
Maximum
Sep 2023
-22.05M
Average
-24.74M
Median
Cash from Operations (TTM) Benchmarks
Janux Therapeutics Inc | -51.50M |
Mersana Therapeutics Inc | -172.53M |
Vera Therapeutics Inc | -99.72M |
NovaBay Pharmaceuticals Inc | -4.516M |
Palatin Technologies Inc | -33.74M |